The global benzodiazepine drugs market was valued at US$ 2.2 Bn in 2023 and is projected to expand at a CAGR of 3.5% from 2024 to 2034, reaching more than US$ 3.2 Bn by 2034. Benzodiazepines are psychoactive medicines primarily prescribed for the management of anxiety disorders, insomnia, seizures, muscle spasms, and certain symptoms associated with alcohol withdrawal. Their therapeutic value...